Effects of EGFR, CK19, CK20 and Survinin Gene Expression on Radiotherapy Results in Patients with Locally Advanced Head and Neck Cancer |
Kekilli, Kezban Esra
(Department of Radiation Oncology, Bursa Ali Osman Sonmez Oncology Hospital)
Abakay, Candan Demioz (Faculty of Medicine, Uludag University) Tezcan, Gulcin (Department of Medical Biology, Uludag University) Tunca, Berrin (Department of Medical Biology, Uludag University) Egeli, Unal (Department of Medical Biology, Uludag University) Saraydaroglu, Ozlem (Department of Pathology, Uludag University) Esbah, Onur (Department of Medical Oncology) Ekinci, Ahmet Siyar (Department of Medical Oncology) Arslan, Sonay (Diyarbakir Gazi Yasargil Education and Research Hospital) Uslu, Nuri (Diyarbakir Gazi Yasargil Education and Research Hospital) Ozkan, Lutfi (Faculty of Medicine, Uludag University) |
1 | Andratschke M, Pauli C, Stein M, et al (2003). MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer. Anticancer Res, 23, 1467-71. |
2 | Cooper JS, Porter K, Malin K (2009). National cancer database report on cancer of the head and neck:10 year update Head Neck. DETAILS?? DOI |
3 | Farnebo L, Jerhammar F, Ceder R, et al (2011). Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines. J Oral Pathol Med, 40, 739-46. DOI |
4 | Forastiere AA, Ang KK, Brizel D, et al (2008). National comprehensive cancer network, head and neck cancers. J Natl Compr Canc Netw, 646-95 |
5 | Khan Z, Khan N, Tiwari RP, et al (2010). Down-regulation of survivin by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells. Radiother Oncol, 96, 267-73. DOI |
6 | Lin JC, Wang WY, Chen KY, et al (2004). Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med, 350, 2461-70. DOI |
7 | Toyoshima T, Vairaktaris E, Nkenke E, et al (2009). Hematogenous cytokeratin 20 mRNA Detection has prognostic impact in oral sguamous cell carsinoma. preliminary results. Anticancer Res, 29, 291-97. |
8 | Tunca B, Egeli U, Cecener G, et al (2012). CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer. Tumori, 98, 243-51. |
9 | Shimada R, Iinuma H, Akahane T, et al (2012). Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients. Oncol Rep, 27, 947-53. |
10 | Venook AP (2005). Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma. Cancer, 103, 2435-46. DOI |
11 | Wollenberg B, Walz A, Kolbow K, et al (2004). Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN. Onkologie, 27, 358-62. DOI |
12 | Yang RN, Yang SH, Chang CC, et al (2010). Upregulation of fecal cytokeratin 19 is associated with prognosis in older colorectal cancer patients. Genet Test Mol Biomarkers, 14, 703-08. DOI |
13 | Zhao S, Liu Y, Zhang Q, et al (2011). The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature. Breast Cancer Res Treat, 130, 809-16. DOI |
14 | Zhong LP, Chen WT, Zhang CP, et al (2007). Increased CK19 expression correlated with pathologic differantiation grade and prognosis in oral sguamous cell carcinoma patients. Oral Surg Oral Pathol Oral Radiol Endod, 104, 377-84 DOI |
15 | Zhu H, Wang Q, Hu C, et al (2011). High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy. Tumour Biol, 32, 1147-53. DOI |
16 | Zimmerman M, Zauhair A, Ozsahin M (2006). The epidermal growth factor reseptor (EGFR) in head and neck cancer its role and treatment implications, Radiat Oncol, 1, 11. DOI |